Advertisement

Topics

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia

20:00 EDT 9 Oct 2017 | Alzheimer's Research and Therapy

The progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) dementia can be predicted by cognitive, neuroimaging, and cerebrospinal fluid (CSF) markers. Since most biomarkers reveal compleme...

Original Article: Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia

NEXT ARTICLE

More From BioPortfolio on "Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...